chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Off and on they've been a little tired; started itching, It was quite intense, it itched in their fingers, arms, the one that they had the shot was itching more than the other/ Chest was itching; woke up in the middle of the night scratching her right arm, couldn't stop scratching; It's a bit red; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (started itching, It was quite intense, it itched in their fingers, arms, the one that they had the shot was itching more than the other/ Chest was itching), SLEEP DISORDER (woke up in the middle of the night scratching her right arm, couldn't stop scratching), VACCINATION SITE ERYTHEMA (It's a bit red) and FATIGUE (Off and on they've been a little tired) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced PRURITUS (started itching, It was quite intense, it itched in their fingers, arms, the one that they had the shot was itching more than the other/ Chest was itching), SLEEP DISORDER (woke up in the middle of the night scratching her right arm, couldn't stop scratching) and VACCINATION SITE ERYTHEMA (It's a bit red). On an unknown date, the patient experienced FATIGUE (Off and on they've been a little tired). The patient was treated with ISOPROPANOL (RUBBING ALCOHOL) (topical) for Adverse event, at an unspecified dose and frequency. On 11-Mar-2021, PRURITUS (started itching, It was quite intense, it itched in their fingers, arms, the one that they had the shot was itching more than the other/ Chest was itching) and VACCINATION SITE ERYTHEMA (It's a bit red) had resolved. At the time of the report, SLEEP DISORDER (woke up in the middle of the night scratching her right arm, couldn't stop scratching) and FATIGUE (Off and on they've been a little tired) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient was not taking any concomitant medications.   This case was linked to MOD-2021-246741 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Follow up information included reporter contact information, treatment information, and new events added. The patient received 2nd vaccine on 28APR2021.
Experiencing adverse reactions to my blood pressure.  Sometimes my blood pressure is on the low side 101/56 and at other times the reading is on the high side 173/72. The clinic has records of my blood pressure readings.
patient felt dizzy immediately after receiving these 2 vaccines, she did not loose consciousness and was able to talk. patient was asked to lay down on exam table, rechecked her breathing, heart rate, skin and lips/ tongue and oropharyngeal cavity which were all normal. patient was monitored for 15 minutes, given water to drink. patient was back to her baseline within 10-15 minutes and was able to go back home walking with her mother.
Same day after getting vaccine. I got really dizzy and my heart raced. Called the Paramedics over and suggested I go to hospital and I declined after speaking with cardiologist. Cardiologist advised I take a xanax. I went home after. Later that day I noticed a little swelling in my wrist. The swelling has Gradually increased to the left side in my wrists and both the backs of my legs. I called my cardiologist Dr and I am waiting for a cb. I spoke to Dr and he said it sounds like I am retaining water and advised me to up my diuretics'.
Friday noc started feeling achey; 230 Saturday morning-woke up w/myalgia, fever 101, chills, tenderness @ inject site w/swelling @ inject site; cont until 18OCT94; saw MD on 17OCT94 dx react to vax;
swelling and pain started on 3-28 late evening. over the course of 4 days swelling has got worse. On elbow location same arm as injection.
headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced HEADACHE (headaches). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported.
VERY severe arm pain, fever, aches, severe fatigue and exhaustion, disturbed sleep.
hypertension, hyperlipidemia, high cholesterol, mennhorrhagia, abnormal menstrual cycles
Information has been received from a pharmacist referring to a patient of unknown age and gender. On 19-FEB-2015 the patient was vaccinated with an expired dose of PNEUMOVAX23, 0.5 ml, intramuscular, lot# not reported, expiration date 29-JAN-2015. No adverse effect was reported at time of reporting. Additional information has been requested.
Swollen Lips (top and Bottom), Face Swelling, Numbness and Tingling, Leg Tingling (thighs) Treatment: Loritidine 2 tablets, 10 mg
Patient accidentally received bivalent booster instead of primary series dose; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient accidentally received bivalent booster instead of primary series dose) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Patient accidentally received bivalent booster instead of primary series dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient accidentally received bivalent booster instead of primary series dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient accidentally received bivalent booster instead of primary series dose).    It was unknown if patient reported any AEs, any treatment was given or if the patient was under any concomitant or regular medication.
The Flu vaccine and Shingles vaccine were both given at the same time on the same day.  I developed symptoms  at about two (2) weeks of numbness/tingling in hands and feet had extreme difficulty walking.  Suffered overall weakness in arm, hands, legs, feet.  After two visits to the ER finally got a diagnosis of Gillian Barre Syndrome.  Seven days in the hospital then inpatient rehab.
Got awful sick; Initial information received on 21-Nov-2020 regarding an unsolicited valid non-serious case from a non-health care professional (patient's son) via social media.  This case involves an adult female patient who got awful sick (illness), while she received vaccine influenza vaccine.  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.   No concomitant medication was reported.  On an unknown date, the patient received a dose of suspect influenza vaccine (produced by unknown manufacturer) (with an unknown route, frequency, strength, lot number and expiry date) for prophylactic vaccination.  On an unknown date (latency unknown) after starting the suspect vaccine therapy, the patient got awful sick (illness).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case.  No further relevant information was reported.
All side effects continue over 3 weeks after vaccine. Angioedema. Hives, initially on chest, then on joints, then throughout the body appearing asymmetrically.  Severe joint pain. Lip and eye lid swelling. Limp arm on 9/19/21.
Low platelet count (59 TH/uL) discovered with routine blood test 3 weeks after second dose; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Feb2021 09:15 (Lot number: EL3247) at the age of 30 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known allergies to kiwi fruit" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, Administration time: 10:30, Vaccine location: Left arm, Lot number: EL3247), administration date: 04Feb2021, when the patient was 30 years old, for COVID-19 immunisation. The following information was reported: PLATELET COUNT DECREASED (non-serious) with onset 16Mar2021, outcome "unknown", described as "Low platelet count (59 TH/uL) discovered with routine blood test 3 weeks after second dose". The event "low platelet count (59 th/ul) discovered with routine blood test 3 weeks after second dose" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of platelet count decreased.  No follow-up attempts are possible. No further information is expected.
Pt. received ZOSTAVAX IN; approx. 6 months ago at a local retail pharmacy (not at one facility).  Pt presented to an ED with other problems, and on assessment appeared to have chicken pox.  Had been exposed to family member w/ severe case of chicken pox within recent time.
Patient received the incorrect vaccine dose- 5 year old received 6mo-4yrs monovalent vaccine instead of monovalent 5-11yr
itchy little red marks scattered over arm and legs that turned into blisters and it's extremely big and red itchy one; itchy little red marks scattered over arm and legs that turned into blisters and it's extremely big and red itchy one; a little red marks that turned into water blisters; blister is burning; The blisters will leak out; The blisters will leak out and will turn into a black scar / mark on body...know some people, 3 people that she knows are experiencing the same side effects; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ERYTHEMA (non-serious), PRURITUS (non-serious), outcome "unknown" and all described as "itchy little red marks scattered over arm and legs that turned into blisters and it's extremely big and red itchy one"; BLISTER (non-serious), outcome "unknown", described as "a little red marks that turned into water blisters"; BURNING SENSATION (non-serious), outcome "unknown", described as "blister is burning"; BLISTER RUPTURE (non-serious), outcome "unknown", described as "The blisters will leak out"; SCAR (non-serious), outcome "unknown", described as "The blisters will leak out and will turn into a black scar / mark on body...know some people, 3 people that she knows are experiencing the same side effects".  Additional Information: Reporter (Female, 48 Years) stated she had both of the Pfizer Covid19 shots and she experienced little red marks that turned into water blisters, and she wants to know what can be done about it. She described it as itchy little red marks scattered over her arm and legs that turned into blisters and it's extremely big and red itchy one. The blisters will leak out and will turn into a black scar. And as we speak one blister is burning, she also added that she know some people, 3 people that she knows are experiencing the same side effects like what she's having. Reporter stated that Pfizer need to look into some serious side effects because this is not good. This side effects of the vaccine will have a mark on her body and all we can do was refer them back to their HCP.  Follow-up attempts completed. No further information is expected.
Pt erupted in vesicles (shingles) & (L) axilla 3-4 d's after administration of Varicella #2 vaccine.
Chills, temp 103F-onset 24 hours post vaccine administration. Prescribed Advil with good response.
Chills; Fever; Fatigue; Headache; Muscle aches; This is a spontaneous report from a contactable consumer (patient). A 42-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number: EK5730, expiration date was not reported) via an unspecified route of administration, in right arm, on 24Mar2021 10:00 (at the age of 42-years-old), at dose 2, single for covid-19 immunization from Workplace clinic. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number: EJ1685, expiration date was not reported) via an unspecified route of administration, in right arm, on 03Mar2021 09:45 (at the age of 42-years-old), at dose 1, single for covid-19 immunization. Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine. The patient has not been tested with covid-19 since the vaccination. The patient experienced chills, fever, fatigue, headache, muscle aches on 24Mar2021 18:30. No treatment was received for the events. The outcome of the events was recovered on Mar2021.    No follow-up attempts are needed. No further information is expected.
fever; leg stiffness; irritability; fine red, raised rash on abd, back, buttocks; pt seen by MD;
Mild induration, minimal tenderness. Erythematous macular rash to site, (R) thigh.
funny feeling; This is a spontaneous report received from a Pfizer-sponsored program. A contactable consumer (patient himself) reported that an unspecified aged male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection) via an unspecified route of administration on 20Jan2021 at single dose for COVID-19 immunization. Patient medical history and concomitant medication were not reported. Patient said that he received his first dose on the 20th Jan and said about 40 mins after his first dose he took two ibuprofen and he took another two ibuprofen 4 hours later. Patient received the first dose of the COVID vaccine. 40 minutes after, he took 1 Advil to avoid feeling any reactions. However, due to a 'funny feeling' he took 2 more in the afternoon. He felt fine afterwards. He stated having multiple 'risk factors'. Outcome of event was recovering.  Information on the lot/batch number has been requested.
This case was reported by a healthcare professional and described the occurrence of hypoglycemia in a 77-year-old male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). The subject is not a diabetic and has a history of chronic kidney disease, stage 4 and on on dialysis. Also has a medical history of anemia and currently has hypertension. There were no concurrent medications. On the morning of 7 October 2008 the subject received unspecified dose of FLULAVAL at 0.5 ml. On 7 October 2008, about 1 hour after vaccination with FLULAVAL, the subject experienced hypoglycemia, sleepiness, lack of energy and feeling unwell. This case was assessed as medically serious by GSK. Product complaint was reported. At the time of reporting the outcome of the events was unspecified. The reporter stated that they gave three doses of FLULAVAL in the morning and three subjects reported hypoglycemia.
Arm was swollen; Arm was red; Nausea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Arm was red), NAUSEA (Nausea) and CHILLS (Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Arm was red), NAUSEA (Nausea) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 15-Apr-2021, NAUSEA (Nausea) and CHILLS (Chills) had resolved. At the time of the report, PERIPHERAL SWELLING (Arm was swollen) and ERYTHEMA (Arm was red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Patient developed an itchy rash on the neck starting 3-4 days after receiving the Moderna vaccine.   Advised patient to speak to doctor about the rash.
Right arm hurt after "administration of the second dose"; This spontaneous report was received from a pharmacist referring to a female patient of currently 68-years old. The patient's medical history, concomitant medications and drug reactions were unknown. The patient's concurrent condition included Sjogren's syndrome.  On 04-OCT-2019, the patient was vaccinated with 1st dose pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 1 dosage form, lot# R016640, expiration date: 28-JAN-2020 (strength, route of administration and anatomical location were unknown) for prophylaxis. On 28-MAY-2019, the patient was vaccinated with 2nd dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection in the right arm (strength, dose, route of administration, lot # and expiration unknown) for prophylaxis. Approximately in May 2019, the patient's right arm was hurt after administration of the second dose (pain in extremity). The reporter recommended that the patient could take acetaminophen (TYLENOL) or aspirin for her "arm pain", but it was unknown whether the patient took the medication. The patient sought medical attention and there was no intervention to prevent the event. The outcome of pain in extremity was unknown.  The causality was not reported. No product quality complaints were involved.
Was sick for 2 weeks. Ran low grade fever and sweat profusely drenching hair and clothes.
pt recv vax;unconsolable crying for 2 hrs beginning several hrs p/ vax;cry was different character than usual;
Pt wanted the covid booster after seeing their doctor. I gave 0.3ml of a Pfizer booster to patient and didn't realize it was expired a few hours before. I called the Patient myself and let her know the situation. an RL6 was placed, CDC was contacted and Pfizer was as well. Patient was a little nauseated but she understood the mistake and she is feeling normal.
Injection went in shoulder joint, severe pain and inability to use arm. We sent her to doctor, she received steroid, antibiotic, muscle relaxer.
Newborn was given the TDAP vaccination instead of the Hepatitis B vaccination. There were no signs or symptoms of an adverse reaction to the TDAP vaccination upon discharge from the hospital. The Hepatitis B vaccination was given on 6/25/2020 prior to discharge from the hospital and two days after the TDAP vaccination was given.
Huge swollen  under right arm lump node. Tired leg  syndrome and joint pain.  Severe  pain in injection site, upper back and neck. weakness. Stiff muscles, dizziness and light headed, flu like symptoms.  Extreme  pain in right arm x 10, swollen red bumbs and rash around  injection site.
Have an allergic reaction all over her body; a rash all over her body; she thought it was eczema that she had had before; she thought it was eczema that she had had before; This is a spontaneous report from a contactable nurse (patient) via Pfizer sales representative. A 37 years old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 16Dec2020 at single dose for COVID-19 immunization. Medical history included a rash on her body in college before and eczema. Concomitant medications were not reported. On 18Dec2020, patient had an allergic reaction all over her body like a rash all over her body, and she thought it was eczema that she had had before. She thought that maybe that could be from the vaccine. Regarding treatment, she took diphenhydramine (BENADRYL, non-Pfizer drug) and it didn't work. Outcome of events was not recovered.  Information on the Batch/Lot number has been requested.
swelling @ inj site noted by parent @ home on 20AUG98;@ appt 21AUG98 swelling brought to attention of MD rx for DPH given;
Immediate reaction in left arm site of injection deep red  rash, skin blotching non-itching . Neck and face rash. Deep purple rash in both feet and toes.  Given 25 mg Benadryl po with resolution of rash in 3 hrs. C/O headache and nausea.
This spontaneous report as received from a registered nurse refers to a 17 year old patient (gender unknown). Pertinent medical history, drug reactions or allergies were not reported.   On 16-DEC-2013, the patient was vaccinated with a dose of ZOSTAVAX, 0.65ml, subcutaneous (lot # was not provided) instead of (Oka/Merck) VARIVAX.  The nurse stated that the patient also received a dose of (Oka/Merck) VARIVAX on an unknown date after receiving ZOSTAVAX. No adverse effect reported.   Additional information is not expected because the reporter refused further follow up.
(L) arm cellulitis, fever, warm to touch, erythema, swelling. Treated with Z pak with no relief - on cephalexin 500 Q 8 hrs.
Started migraines about once a week and then they increased to about every other day; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Started migraines about once a week and then they increased to about every other day) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Started migraines about once a week and then they increased to about every other day). The patient was treated with ATOGEPANT (oral) ongoing from November 2021 for Migraine, at a dose of 60 mg once a day. At the time of the report, MIGRAINE (Started migraines about once a week and then they increased to about every other day) had resolved. Not Provided          No concomitant medications were reported.
Rash and swelling in the shoulder area from injection site downward.  approximately 4 inches wide and 6 inches long.
pt recv vax & w/in a few hr devel a probable allergic rxn:seen in ER sx itching-hives both arms, side of face;tx DPH;
Client began to feel numbness and tingling in her lower jaw and lip approx 15 minutes after leaving.  Her face tightened and it became difficult for her to move her jaw. Numbness spread upward toward her temple. She returned for evaluation. S/S began to fade and by the time she returned she could move her jaw and felt face muscles relaxing.